Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular Age-related Macular Degeneration (AMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04486963
What this trial is testing

A Phase Ⅱ Clinical Study of Sanhuangjingshimingwan in Wet( Neovascular)Age-related Macular Degeneration(wAMD) Subjects

Who this might be right for
Age-related Macular Degeneration
Tasly Pharmaceutical Group Co., Ltd 78
Large-scale testing (Phase 3)Study completedNCT05282004
What this trial is testing

Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Vial Kit

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Sandoz 36
Large-scale testing (Phase 3)Study completedNCT00685100
What this trial is testing

Retinal Effects After Combined Photodynamic Therapy (PDT) With Intravitreal Triamcinolone

Who this might be right for
Neovascular Age Related Macular Degeneration
Medical University of Vienna 40
Early research (Phase 1)Study completedNCT01186432
What this trial is testing

Preliminary Safety and Efficacy of the PDS-1.0 in Patients With Neovascular Age Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
Forsight Vision4 20
Testing effectiveness (Phase 2)Ended earlyNCT03465709
What this trial is testing

Pegcetacoplan (APL-2) in Neovascular AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Apellis Pharmaceuticals, Inc. 17
Testing effectiveness (Phase 2)Study completedNCT01157715
What this trial is testing

A Randomized, Double-masked, Multicenter, Controlled Study of Intravitreal KH902 in Patients With Neovascular AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Chengdu Kanghong Biotech Co., Ltd. 122
Early research (Phase 1)Study completedNCT04058535
What this trial is testing

Clinical Study of ALT-L9 to Determine Safety, Efficacy and Pharmacokinetics in Neovascular AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Alteogen, Inc. 28
Large-scale testing (Phase 3)Looking for participantsNCT04663750
What this trial is testing

Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).

Who this might be right for
Eye DiseasesMacular Degeneration, WetSub-Macular Hemorrhage
King's College Hospital NHS Trust 210
Early research (Phase 1)UnknownNCT03021785
What this trial is testing

Multiple Intravitreal Injection TK001 in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Jiangsu T-Mab Biopharma Co.,Ltd 36
Post-approval studies (Phase 4)Ended earlyNCT04287348
What this trial is testing

Intravitreal Brolucizumab in Neovascular Age-related Macular Degeneration With Limited Response to Aflibercept

Who this might be right for
Neovascular Age-related Macular Degeneration
Vista Klinik 16
Testing effectiveness (Phase 2)Ended earlyNCT05571267
What this trial is testing

Safety Study of Zimura in Combination With Anti-VEGF Therapy in Patients With Neovascular AMD

Who this might be right for
Neovascular Age-Related Macular Degeneration
IVERIC bio, Inc. 1
Large-scale testing (Phase 3)Active Not RecruitingNCT04704921
What this trial is testing

Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD

Who this might be right for
AMDnAMDWet Age-related Macular Degeneration+6 more
AbbVie 671
Not applicableNot Yet RecruitingNCT07581782
What this trial is testing

Prospective, Single Arm, Observational Study of Faricimab in the Treatment of Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration(nAMD)
Sun Yat-sen University 50
Not applicableUnknownNCT05220085
What this trial is testing

Beovu Experience UZ Leuven

Who this might be right for
Age-Related Macular Degeneration
Universitaire Ziekenhuizen KU Leuven 17
Testing effectiveness (Phase 2)Study completedNCT03022318
What this trial is testing

Carbidopa-levodopa in Neovascular AMD

Who this might be right for
Age-related Macular Degeneration
Snyder, Robert W., M.D., Ph.D., P.C. 20
Testing effectiveness (Phase 2)Looking for participantsNCT06492863
What this trial is testing

Gene Therapy(FT-003) for Wet AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Frontera Therapeutics 78
Not applicableStudy completedNCT04455399
What this trial is testing

Time Efficiency Comparison of Two IntraVitreal Injection Techniques

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion With Macular Edema+2 more
Peregrine Eye and Laser Institute 200
Not applicableStudy completedNCT05131646
What this trial is testing

Extension Study to Evaluate the Long-term Outcomes of Subjects in the CLS-AX CLS1002-101 Study

Who this might be right for
Neovascular Age-related Macular Degeneration
Clearside Biomedical, Inc. 15
Large-scale testing (Phase 3)Study completedNCT00967213
What this trial is testing

Combination of Ranibizumab and Verteporfin Therapy in Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Korea Ltd. 10
Large-scale testing (Phase 3)WithdrawnNCT00390026
What this trial is testing

The Avastin vs Visudyne for Neovascular AMD Study

Who this might be right for
Age-related Macular Degeneration
St. Erik Eye Hospital
Next Page